Konstantinos Kelaidonis

发表

A Global Review on Short Peptides: Frontiers and Perspectives

Elham Mousavinezhad Sarasia, V. Apostolopoulos, K. Parang, 2021, Molecules.

Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation

Theodore V. Tselios, J. Matsoukas, Konstantinos Kelaidonis, 2011, Amino Acids.

Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy

V. Apostolopoulos, G. Moore, J. Matsoukas, 2022, Viruses.

Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System

G. Moore, J. Bojarska, J. Matsoukas, 2022, Molecules.

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19

V. Apostolopoulos, G. Moore, J. Matsoukas, 2021, Biomolecules.

From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy

V. Apostolopoulos, G. Moore, J. Matsoukas, 2021, Molecules.

Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2

Christos T. Chasapis, V. Apostolopoulos, G. Moore, 2022, Biomedicines.

Facile and Efficient Syntheses of a Series of N-Benzyl and N-Biphenylmethyl Substituted Imidazole Derivatives Based on (E)-Urocanic acid, as Angiotensin II AT1 Receptor Blockers

Theodore V. Tselios, J. Matsoukas, Konstantinos Kelaidonis, 2013, Molecules.

An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT1 Angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies

Serdar Durdagi, Thomas M. Mavromoustakos, John Matsoukas, 2010, J. Comput. Aided Mol. Des..

Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan

Christos T. Chasapis, V. Apostolopoulos, J. Matsoukas, 2021, Brain sciences.

The Human Myelin Proteome and Sub-Metalloproteome Interaction Map: Relevance to Myelin-Related Neurological Diseases

Christos T. Chasapis, V. Apostolopoulos, J. Matsoukas, 2022, Brain sciences.

Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity

Christos T. Chasapis, V. Apostolopoulos, J. Matsoukas, 2023, Viruses.

Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019

V. Apostolopoulos, G. Moore, J. Matsoukas, 2023, Biomolecules.

Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes

Christos T. Chasapis, G. Moore, J. Matsoukas, 2023, Proteomes.

Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2

Christos T. Chasapis, V. Apostolopoulos, V. Gorgoulis, 2022, Computational and Structural Biotechnology Journal.

W254 in furin functions as a molecular gate promoting anti-viral drug binding: Elucidation of putative drug tunneling and docking by non-equilibrium molecular dynamics

J. Matsoukas, Konstantinos Kelaidonis, J. Orbell, 2023, Computational and structural biotechnology journal.

Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 Therapeutics

Christos T. Chasapis, Veroniki P. Vidali, G. Moore, 2023, International journal of molecular sciences.

Structural Features Influencing the Bioactive Conformation of Angiotensin II and Angiotensin A: Relationship between Receptor Desensitization, Addiction, and the Blood–Brain Barrier

Veroniki P. Vidali, Konstantinos Kelaidonis, Minos-Timotheos Matsoukas, 2024, International journal of molecular sciences.

Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies

Veroniki P. Vidali, Konstantinos Kelaidonis, S. Tsiodras, 2024, Expert opinion on therapeutic targets.